NSE - Delayed Quote INR

Indoco Remedies Limited (INDOCO.NS)

250.54
-1.32
(-0.52%)
At close: 3:30:00 PM GMT+5:30
Loading Chart for INDOCO.NS
  • Previous Close 251.86
  • Open 254.80
  • Bid --
  • Ask --
  • Day's Range 250.00 - 255.10
  • 52 Week Range 190.00 - 387.55
  • Volume 44,910
  • Avg. Volume 96,868
  • Market Cap (intraday) 23.163B
  • Beta (5Y Monthly) 0.34
  • PE Ratio (TTM) --
  • EPS (TTM) -1.59
  • Earnings Date May 22, 2025
  • Forward Dividend & Yield 1.50 (0.60%)
  • Ex-Dividend Date Sep 19, 2024
  • 1y Target Est 291.20

Indoco Remedies Limited manufactures, markets, and sells formulations and active pharmaceutical ingredients in India and internationally. It offers stomatological, gastrointestinal, respiratory, anti-infectives, vitamins/minerals/nutrients, ophthal/ontological, dermatology, urological, anti-diabetic, gynaecological, lifestyle management, pain/analgesic, and cardiac products. The company also provides branded generics comprising analgesic tablets and topical preparations; anti-hypertensive; protein supplements; multivitamin tablets and syrups; antibiotic tablets, syrups, and injectables; oral rehydration powders; antacids; and antihistaminic, as well as anti-haemorrhoidal creas and calcium preparations. In addition, it provides analytical services, such as impurity profile, particle size analysis, polymorphism and compatibility studies, heavy metal analysis, extractables and leachables studies, lyophilization studies, reference and working standards, forced degradation studies, and chromatographic method development and validation services. Further, the company offers architectural design, lighting, mechanical and utility engineering, project and construction management, electrical, control system, piping, structural design, data transfer system, and process engineering. Additionally, it provides contract research services, such as custom synthesis of molecules and intermediates, process chemistry research and development, non-infringing process designing and scale up, and analytical method development/validation solutions, as well as contract manufacturing services. The company also exports its products. The company was formerly known as Indo Continental Trading Company. Indoco Remedies Limited was founded in 1945 and is based in Mumbai, India.

www.indoco.com

6,000

Full Time Employees

March 31

Fiscal Year Ends

Recent News: INDOCO.NS

View More

Performance Overview: INDOCO.NS

Trailing total returns as of 5/15/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

INDOCO.NS
24.58%
S&P BSE SENSEX (^BSESN)
5.62%

1-Year Return

INDOCO.NS
23.20%
S&P BSE SENSEX (^BSESN)
13.08%

3-Year Return

INDOCO.NS
24.52%
S&P BSE SENSEX (^BSESN)
56.33%

5-Year Return

INDOCO.NS
13.65%
S&P BSE SENSEX (^BSESN)
165.39%

Compare To: INDOCO.NS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: INDOCO.NS

View More

Valuation Measures

As of 5/14/2025
  • Market Cap

    23.28B

  • Enterprise Value

    31.18B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.27

  • Price/Book (mrq)

    2.13

  • Enterprise Value/Revenue

    1.84

  • Enterprise Value/EBITDA

    17.84

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -0.62%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    17.24B

  • Net Income Avi to Common (ttm)

    -106.6M

  • Diluted EPS (ttm)

    -1.59

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    417.3M

  • Total Debt/Equity (mrq)

    76.63%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: INDOCO.NS

View More

People Also Watch